Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.
about
Immunobiology and immunotherapy in genitourinary malignanciesImmune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer TherapeuticsMolecular cancer prevention: Current status and future directionsLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionImmunotherapy in genitourinary malignancies.Update on the management of non-muscle invasive bladder cancer.The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.Immunotherapy for bladder cancer.Use of bacille Calmette-Guérin in superficial bladder cancer.Microorganisms and cancer: quest for a therapy.Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group.Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune responseManagement and outcome of Bacille Calmette-Guérin vaccine adverse reactions.Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer.In vitro regulation of cell growth and angiogenesis by inositol hexaphosphate in bladder cancer.Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.New Strategies in Bladder Cancer: A Second Coming for Immunotherapy.The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non-Muscle-Invasive Bladder Cancer.Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells.Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladderInduction of tumour necrosis factor-alpha (TNF-alpha) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Guérin.Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer.Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.
P2860
Q26738668-8F843600-6977-4276-BB72-DE32A6B51F30Q26784480-D5BFBE00-3550-476C-9BD0-2052CEF4794BQ26797207-DA0512AD-767A-41BB-A001-F9D2DD5BAA60Q26850218-1E72F9DA-325F-48EC-BC75-CA677F7957A6Q33593800-7597895D-D382-4792-A7D3-DA743720A312Q33613070-78B63FC9-D65C-4F24-ABAB-A5D40EFB5CD9Q34147692-201602AC-11ED-41EA-A387-089928C9ECF5Q34477444-CE118877-305C-4800-89E0-A07BA0724184Q34788204-E4C9BEB8-D9D9-4418-B978-70AE98256892Q34983790-6F3F83DC-955B-49B8-B0AD-6B0AB779FB2BQ35981625-4079DFA0-C314-4A10-AC84-28EB6250FE0BQ36038379-A2EF754C-0BAA-4A3D-B4E0-7D55CFDCB097Q36092315-F2064F05-FC40-4F22-8C39-DAF422EE7313Q36373370-E06E78B6-F8E5-430D-8E1E-EBE06B29C99AQ37197530-E6DA9FB1-1CB3-4DDB-8853-E736BFA27267Q37198053-7EE17ABA-FF68-4658-B2BC-20BAD5669F93Q38621223-974A0F7E-615C-45AF-AF43-AA17B0B0FA31Q38673585-18042D39-8BE8-449A-A15A-0B1ECF99B6C5Q38684886-274937FA-0EF1-478D-A003-4F823FF19C6FQ39586831-A4CD1921-CDBC-4612-8BAA-2593CB2E627EQ39740932-BF69CF4B-D00C-4B92-8D44-9AB4AB8C0B0CQ40545635-3B4A16C1-584F-4231-A727-4DB905E70D71Q41207976-D4AE6E33-FD68-435A-A6B1-509E3A854A83Q41354707-D8C1DAD4-D80F-4CF3-A836-92F1F3EA1854Q47220897-4BFE02C8-202E-4E23-BE49-85C13BBDC029Q54940106-7BE8C83C-6665-4845-9921-F4EE7B0C50A4
P2860
Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.
@en
type
label
Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.
@en
prefLabel
Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.
@en
P2093
P1476
Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer
@en
P2093
P356
10.1016/S0022-5347(17)55282-9
P407
P577
1980-07-01T00:00:00Z